Lynparza 50 mg hard capsules *
Company:
AstraZeneca Pharmaceuticals (Ireland) DACStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Product Notice
Discontinued Strength Notice
Reminder: Lynparza 50 mg Hard Capsules have been discontinued. It is expected that stock will be depleted by December 2021.